Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial
Crossref DOI link: https://doi.org/10.1007/s11255-017-1507-0
Published Online: 2017-01-20
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ren, Hong
Li, Xiao
Ni, Zhao-Hui
Niu, Jian-Ying
Cao, Bin
Xu, Jie
Cheng, Hong
Tu, Xiao-Wen
Ren, Ai-Min
Hu, Ying
Xing, Chang-Ying
Liu, Ying-Hong
Li, Yan-Feng
Cen, Jun
Zhou, Rong
Xu, Xu-Dong
Qiu, Xiao-Hui
Chen, Nan
License valid from 2017-01-20